Cohen Cheryl
SEC-identified person · CIK 1529371 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Celldex Therapeutics, Inc. CLDX | Director | filed 2022 - 2026 |
| Nantkwest, Inc. NK | Director | filed 2019 - 2026 |
| MEI Pharma, Inc. MSHL | Director | filed 2020 - 2022 |
| Zeta Acquisition Corp II WHWK | Director | filed 2018 - 2021 |
| Peak Bio, Inc. PKBO | Director | filed 2021 - 2021 |
| Tokai Pharmaceuticals Inc TKAI | Director | filed 2015 - 2019 |
| Vital Therapies INC VTL | Director | filed 2015 - 2018 |
| Ladrx Corp cytr | Director | filed 2015 - 2015 |
| Medivation, INC. MDVN.OB | Chief Commercial Officer | filed 2011 - 2014 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.